Thermal Metabolic Imprint Analysis for Specific Cancer Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer detection methods lack specificity and sensitivity, often detecting nonspecific signals and compromising detection accuracy due to weaker specific molecular signals being overshadowed by background noise.
Innovation Solution
Analyze metabolic imprints of cells using thermal and thermodynamic quantities derived from naturally emitted infrared radiation, calculating a specificity index and diagnostic score to map on a universal cancer diagnostic scale for precise cancer detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current cancer detection methods use specific molecular signatures for detection, then detection specificity is improved, but detection sensitivity deteriorates because specific molecular signals are much weaker than background signals from other molecular interactions
Solution Approach 1:
The patent introduces an intermediary approach by using machine learning algorithms as a mediator between the detection signal and interpretation. The system processes multiple molecular interaction signals through trained algorithms that have learned to distinguish cancer-specific patterns from background noise, thereby resolving the contradiction between detecting weak specific signals and filtering strong background signals
Solution Approach 2:
The patent changes the detection parameters by shifting from relying on single specific molecular signatures to analyzing multiple parameters simultaneously through machine learning. The system evaluates various molecular interaction characteristics and combines them using algorithms, transforming the detection approach to achieve both high specificity and sensitivity by considering the overall pattern rather than isolated signals
2Quantity of substance
If bulk imaging or tomography is used to detect nonspecific shadows as tumors, then detection coverage is improved, but detection precision deteriorates due to lack of specificity
Solution Approach 1:
The patent applies segmentation by breaking down the bulk imaging data into individual molecular interaction events. Instead of treating the entire image as a single detection target, the system segments and analyzes discrete molecular interactions, allowing specific cancer-related signals to be identified and distinguished from nonspecific background shadows through pattern recognition
Solution Approach 2:
The patent adds another dimension to detection by incorporating machine learning analysis as a computational layer. This transforms the detection from purely spatial (bulk imaging) to include a computational dimension where algorithms evaluate the characteristics of detected signals, enabling differentiation between specific cancer signals and nonspecific shadows based on learned patterns rather than just physical presence
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances cancer detection specificity and sensitivity, enabling accurate identification of rare and subtle cancer types, including those difficult to diagnose by human eye or machine learning, and monitoring treatment efficacy in real-time.
Implementation Method 1
extracting thermal and thermodynamic quantities and properties from the molecular imprints (e.g., from naturally emitted infrared radiations (IR) of cells/tissues)
Data Source
AI summary
Presented herein are systems, methods, and apparatus that analyze molecular imprints for detecting cancerous cells. Embodiments of the present disclosure include systems, methods, and apparatus that analyze metabolic imprints of cells for cancer detection. In certain embodiments, the methods/systems comprise extracting thermal and thermodynamic quantities and properties from the molecular imprints. The thermal/thermodynamic quantities and/or further-processed quantities can be mapped on a universal cancer diagnostic scale for disease stratification, thereby providing/determining a normality status of the subject cells.